Yuhan Corporation is an integrated healthcare company founded in 1926. It has achieved top market value and sales revenue in Korean pharmaceutical industries, and been awarded for the most respected and trusted company in Korea for recent 11 consecutive years. It has two subsidiaries, Yuhan Chemical and Yuhan Medica, and the affiliates including Joint Ventures with Janssen(Belgium), the Clorox Company(USA), and Kimbery-Clark Corporation(USA). The core business of Yuhan can be classified into Primary & Specialty care, Dietary supplement, Household & Animal care, and contract manufacturing of active pharmaceutical ingredients.
1 signal in the last 90 days.
The order this company entered each market — oldest to newest
Yuhan Partners with Heuino for MEMO Cue
Yuhan's Lesigercept enters multi-national Phase 2 trial
Sign up to see the full signal feed
How Yuhan Corporation's international expansion compares to its competitors
Yuhan CorporationYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Yuhan CorporationYou | 1 | 0 | -100% | 1 | 11 |
제약 영업사원
View postingSeoul, South Korea · 7mo ago
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Yuhan Corporation to hold 103rd annual shareholders meeting on March 20th, discussing financial statements and dividend of 600 won per common share.
Yuhan Corporation will hold its 103rd regular shareholders' meeting on March 20th, discussing financial statements and dividend approval of 600 won per common share.
A new book analyzes drug development as an industrial battlefield involving capital, technology, and business strategy, covering obesity, cancer, immune, and brain disease treatments with global pharmaceutical competition.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Yuhan Corporation's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
